Skip to content

Clinical trials

Phase 2 Wet Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Wet Macular Degeneration Phase: Phase 2 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20112
20122
20141
20151
20171
20181
20192
20201
20211
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Terminated2
Unknown status2
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AbbVie2
Adverum Biotechnologies, Inc.1
Anne Fung MD1
Boehringer Ingelheim1
Iconic Therapeutics, Inc.1
Kapil Kapoor1
McMaster University1
Oraya Therapeutics, Inc.1
Sylentis, S.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Wet Macular Degeneration16
Macular Degeneration10
Vision Disorders4
Choroidal Neovascularization2
Eye Diseases2
Geographic Atrophy2
Macular Edema2
Retinal Vein Occlusion2
Blindness1
Diabetic Retinopathy1

Trials

Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.